细胞工程

891449 酿酒酵母原生质体融合及其融合子的鉴定[中] 应用原生质体融合技术,得到乙醇产量较高的两株多倍体酵母菌融合子F_23和F_38,融合频率为2×10~[-5]。测定融合子F_23、F_33每个细胞内DNA含量分别为2.14×10~[-3]     

酿酒酵母和产朊假丝酵母原生质体的形成、再生及属间融合

使用由亚硝基胍诱变所得到的营养缺陷型作为单倍体融合亲株的核基因标记,同时也采用线粒体球红霉素抗性突变株的小菌落形式作为融合亲株的线粒体基因标记。酿酒酵母(Saccharomyces cerevisiae)和产朊假丝酵母(Candida utilis)两亲株原生质体的制备是用对数生长早期的细胞在蜗牛酶和0.7M KCl及β-巯基乙醇或二巯基苏糖醇的作用下完成的。二者的原生质体的形成率在30—60分钟内达到90—99％。原生质体再生率,酿酒酵母最高为29—35％,产朊假丝酵母为7.5％。两亲株的原生质体在35％PEG(M.W.6,000),10mM CaCl_2条件下被诱导融合。在基础培养基上,长出以营养互补为标记的融合菌株。融合频率为10~(-5)—10~(-6)。试验表明,这些融合菌株具有杂种的性质。其中一株杂合子在同化D-木糖、纤维二糖等的能力上比亲株明显增强。     

酵母属间原生质体融合改进菌株木糖发酵性能

通过单倍体分离和紫外诱变,获得了１４株树干毕赤酵母（Ｐｉｃｈｉａｓｔｉｐｉｔｉｓ）７１２４和酿酒酵母（Ｓａｃｈａｒｏｍｙｃｅｓｃｅｒｅｖｉｓｉａｅ）１３００的营养缺陷型突变株。用聚乙二醇（ＰＥＧ）和电诱导融合及致死融合等方法,实现了树干毕赤酵母和酿酒酵母的属间原生质体融合。融合子能发酵木糖产生酒精,其厌氧发酵木糖和木糖葡萄糖混合液的能力明显优于亲株,耐酒精的性能也比亲株树干毕赤酵母７１２４有所提高。融合子经ＤＮＡ含量、细胞体积测定和稳定性能实验证明为稳定融合子。     

酿酒酵母缺陷型原生质体的形成再生及融合条件的探讨

营养缺陷型作为酿酒酵母(Saccharomyces Cerevisiae)单倍体融合亲株的遗传标记。采用营养缺陷型LY—2和LY—4菌侏的对数生长前期的细胞,在0.5％的蜗牛酶作用时间40分钟,0.7MKCl高渗稳定剂的条件下,制备原生质体。两亲株的原生质体形成率分别为98.2％和91.0％。原生质体再生率为6.12％和2.13％。两亲株的原生质体在35％聚乙二醇(PEG, M.W.6000),50mMCaCl_2下诱导融合15分钟,在基本培养基上长出营养互补的融合菌株,融合频率为4.14x10_(-4)。本文就两亲株的原生质体形成和再生条件进行了初步的探讨,并进行了原生质体融合的尝试,     

酿酒酵母W5及休哈塔假丝酵母20335原生质体制备条件的确定

确定了酿酒酵母W5及休哈塔假丝酵母20335原生质体制备的最佳条件。选取不同脱壁预处理时间及不同酶解时间,对酿酒酵母W5、休哈塔假丝酵母20335进行原生质体制备和再生,比较制备率和再生率。确定脱壁预处理30 min后,以终浓度2%的蜗牛酶,30℃、100 r/min酶解处理15 min为双亲株原生质体制备的最佳条件。利用原生质体融合的方法,以酿酒酵母W5和休哈塔假丝酵母20335为亲本株,构建可以利用木糖生产生物乙醇的新型酿酒酵母融合株,该前期工作为W5、20335原生质体融合工作奠定了重要的基础,对于将木质纤维素原料转化为生物乙醇的研究具有极其重要的意义。     

灭活原生质体融合选育木糖、葡萄糖共发酵酿酒酵母工程菌

为了选育高效利用木糖、葡萄糖共发酵,并使乙醇产量有所提高的酿酒酵母工程菌株。以酿酒酵母Saccharomyces cerevisiae W5和休哈塔假丝酵母Candida shehatae 20335为亲本株,确定了双亲株原生质体灭活剂量,并进行原生质体融合获得融合子,用高效液相色谱（HPLC）测定融合子以木糖、葡萄糖单碳源及混合碳源发酵时的乙醇得率。结果表明,获得一株发酵性能优良的融合子HDY2-14,其利用木糖和葡萄糖单碳源发酵的乙醇得率分别为0.213g/g和0.257g/g,混合碳源发酵的乙醇得率为0.310g/g,其中混合碳源乙醇得率比亲本株W5和20335的乙醇得率分别提高了20.2%和15.2%。     

酿酒酵母单倍体与双倍体原生质体的融合*

本文报道用酿酒酵母(Saccharomyces cerevisiae)原生质体融合,得到营养互补的融合子为三倍体,其生长速度、发酵速率均较亲株提高1—2倍。部分融合子酒精的产量高于亲株,同时高于目前使用的酒精发酵生产菌株。     

酿酒酵母单倍体与双倍体原生质体的融合

本文报道用酿酒酵母(Saccharomyces cerevisiae)原生质体融合,得到营养互补的融合子为三倍体,其生长速度、发酵速率均较亲株提高1—2倍。部分融合子酒精的产量高于亲株,同时高于目前使用的酒精发酵生产菌株。     

电诱导酵母属与短梗霉属属间融合的研究

本文报道了经GH一401 型电诱导细胞融合、基因转移仪诱导实现的酿酒酵母(Saccharomyces cerevisiae NK491) 与出芽短梗霉 (Aureobasidium pullulans NKB93—0061eu)的原生质体电诱导融合。在融合小罐中用3个强度为11 Kv／cm,时程为10μs的高压电脉冲处理原生质体,获得的融合子营养互补的融合频率为5.8×10^-5。在选择培养基上连续传代10次,然后在完全培养基上传代20次,最终得到4株稳定的融台子。融合子的细胞形态、大小、核的DNA含量以及酒精发酵等特性的观察和测定表明,4株融合子与双亲均有明显差异。实验结果表明,电诱导原生质体融台对酵母菌的属间融合是一种行之有效的方法,具有较高的融合频率。     

原生质体电诱导融合构建高温酿酒酵母

研究了采用原生质体电融合构建高温酿酒酵母。对影响电融合效率的几个参数、高温浓醪发酵和融合子遗传稳定性等方面进行了研究。确定了进行电诱导融合的最佳条件 ,并选出了 1株融合株。     

牛乳铁蛋白肽(LfcinB)在苏云金芽胞杆菌中的融合表达

牛乳铁蛋白肽（bovine lactoferrincin,LfcinB）来源于牛乳铁蛋白（bovine lactoferrin）,是目前已知所有乳铁蛋白肽中活性最高的。前期研究表明,可以通过大肠杆菌表达体系和毕赤酵母表达体系表达有活性的LfcinB,但得到的产物难以纯化,产量也不理想,所以研究构建新型的LfcinB表达体系有很重要的意义。苏云金芽胞杆菌（Bacillus thuringiensis, Bt）能在芽胞形成的同时产生一种δ-内毒素组装成的杀虫晶体,在发酵完成后细胞裂解,将芽胞和晶体释放到培养基中。基于Bt的这种优势,将LfcinB与分子量为35kDa的Cry60Ba晶体蛋白作融合表达。通过PCR扩增和酶切连接,将LfcinB基因连接到 cry60Ba 的下游,构建融合基因并转入无晶体Bt菌株中表达,得到了工程菌4Q7/pPFT60Ba-LfcinB。利用GYS培养发酵48h,再经过超声破碎、包涵体纯化,SDS-PAGE分析表明,工程菌表达了一条38kDa左右的蛋白质条带。将纯化的融合蛋白盐酸水解后进行SDS-PAGE分析,得到近似于3kDa的蛋白质条带,挖取目的条带进行胶内酶解和质谱分析,质谱结果显示,挖取的目的条带样品为LfcinB蛋白的特异性肽段,说明在酸水解过后,融合蛋白Cry60Ba-LfcinB中的Cry60Ba和LfcinB分离开,得到单独的LfcinB蛋白。由此可见,利用晶体蛋白在苏云金芽胞杆菌中进行融合表达可能作为一种新型有效的LfcinB的高效表达体系,为采用基因工程的方法大量生产具有活性的牛乳铁蛋白肽LfcinB蛋白奠定基础。     

The oxidized pyrimidine ribonucleotide, 5-hydroxy-CTP,is hydrolyzed efficiently by the Escherichia coli recombinant Orf135 protein

The Escherichia coli orf135 gene encodes a 15.4kDa protein with homology to the MutT family of nucleotide hydrolases. The orf135 gene was cloned within a glutathione S-transferase (GST) fusion protein expression vector, which was used to overproduce the GST-Orf135 fusion protein in E. coli. The fusion protein thus obtained was purified by affinity column chromatography and gel filtration chromatography from the crude extract. The recombinant Orf135 protein was obtained by removing the GST tag from the purified fusion protein. Various oxidized nucleotides were tested as substrates for the recombinant Orf135 protein. As a result, we found a novel 5-hydroxy-CTPase activity of Orf135, but the hydrolyzing activities for the other nucleotides, including 5-hydroxy-dCTP, were very low. The activation constant (K(a)) of Mg(2+) for the 5-hydroxy-CTPase activity was 1.2 mM, and the pH optimum was 8.5. The catalytic efficiency (k(cat)/K(m)) for this activity was 630 s(-1) mM(-1) at 30 degrees C, which was 30-fold higher than that for the CTPase activity. This result indicates that 5-hydroxy-CTP is the best substrate of Orf135 among the nucleotides tested.     

抗菌肽PekⅡ基因在大肠杆菌中的融合表达及初步纯化

目的：研究抗菌肽PekⅡ基因在大肠杆菌中的融合表达并初步纯化。方法：根据大肠杆菌密码子的偏好性,人工设计并合成2段核苷酸序列,退火获得PekⅡ基因;将此基因克隆到原核表达载体pGEX-4T-2中,构建成抗菌肽基因PekⅡ融合表达载体pGEX-PekⅡ,转化至大肠杆菌BL21中,用IPTG进行诱导。取超声破碎后的上清经Glutathione SepharoseTM4亲和层析得到纯化融合蛋白。结果：PCR和测序表明已获得正确PekⅡ编码基因,SDS-PAGE显示29kD处有特异性的蛋白条带出现,纯化得到的GST-PekⅡ经MALDI-TOFMS分析得出其相对分子质量为29553．03。结论：抗菌肽PekⅡ基因在大肠杆菌中的融合表达获得成功,初步纯化得到纯品。     

The characteristics of the course of mitosis in polykaryons formed during cell fusion]

A new method of cell fusion is proposed utilizing treatment with 15% solution of DMSO in serum before and after PEG treatment. With such treatments in SPEV cell culture a higher rate of cell fusion was obtained than that with other known methods of cell fusion. In the first wave of mitoses (0.5-4 h) mainly asynchronous division of nuclei, premature chromosome condensation and formation of telophase-like nuclei were observed in polykaryons. In the period of the second wave (14-20 h), mitoses were mainly synchronous and completed with cytokinesis. Micronuclei were formed frequently as a result of such mitoses. After the first wave of mitoses the number of polykaryons with pycnotic chromosomes sharply increased, and after the second wave of mitoses the number of polykaryons with pycnotic nuclei increased. The results obtained allow to conclude that heterophasic condition of the fused cells is one of the causes of pathological mitosis of polykaryons and of their death.     

用CHEF凝胶电泳探测远缘担子菌间原生质体融合后的染色体变异

用电场诱导灰盖鬼伞(Coprinus cinereus Co5104,his~-)和佛罗里达侧耳(Pleurotusflorida Pf67, ade~-)两菌株的原生质体融合,获得了两类属间融合子:一类为不断发生分离的单核体,另一类为稳定的双核异核体。利用等高钳位均匀电场(CHEF)凝胶电泳技术比较融合子与两亲本的染色体长度多型性(CLP),显示出融合子的染色体变异以整条染色体的丢失为主。结合形态观察和DAPI核荧光染色的结果,推测单核融合子在胞质融合后很可能发生了核融合,但来自亲本Pf67的染色体不断丢失,最后融合子的遗传组成以来自Co5104的染色体为主;而双核融合子在质配之后可能并未发生核配,不过,来自各亲本的染色体最终均只有部分得以保留在融合子中。     

鲑鱼降钙素基因在大肠杆菌中的克隆与表达

以鲑鱼基因组ＤＮＡ为模板,采用ＰＣＲ获得ｓＣＴ基因,并为ＤＮＡ序列分析所证实．以ｐＧＥＸ－３Ｘ为表达载体,利用体外定点突变技术成功地构建了融合蛋白ＧＳＴ－ｓＣＴ的重组表达质粒ｐＧＥＸ－３Ｘ－ｓＣＴ,在大肠杆菌中得到高效表达,其表达量约为菌体总蛋白的３０％;利用亲合层析法对融合蛋白ＧＳＴ－ｓＣＴ进行纯化,再经Ｆａｃ－ｔｏｒΧａ酶切后获得了重组ｓＣＴ,并对其进行活性检测．初步实验证明,重组ｓＣＴ具有较强的生物活性     

Construction and structural modeling of a single-chain Fv-asparaginase fusion protein resistant to proteolysis

In this study, we construct a fusion protein composed of L-asparaginase (ASNase; from Escherichia coli AS 1.357) and a protective single-chain Fv (scFv), which was selected from a phage-display scFv library from our previous studies. The antibody moiety of the fusion protein was fused to the N-terminus of the enzyme moiety via a linker peptide, (Gly(4)Ser)(6). Recombinant plasmid pET-SLA was constructed to express scFv-ASNase fusion to high levels in E. coli and the expressed product was found to form inclusion bodies. We obtained a soluble fusion protein by refolding and purification. The soluble fusion protein exhibited about 82% of the enzymatic activity of the native ASNase at the same molar concentration, and had a K(m) value similar to that of the native enzyme for the substrate L-asparagine. Importantly, the fusion protein was more stable than native ASNase. In addition: (1) following treatment with trypsin, alpha-chymotrypsin, and rennet, at 37 degrees C for 30 min, scFv-ASNase fusion retained 94.0%, 88.8%, and 84.5% of its original activity, respectively, whereas native ASNase became inactive; and (2) ScFv-ASNase fusion had a much longer in vitro half-life (9 h) in serum than the native enzyme (2 h). The three-dimensional structure of the fusion protein was obtained by modeling with the Homology and Discover modules of the INSIGHT II software package. On the basis of the structural evidence and biochemical properties, we propose that the scFv moiety of the fusion protein may confer ASNase moiety resistance to proteolysis as a result of both steric hindrance and a change in the electrostatic surface of the enzyme.     

鼠抗人纤维蛋白单链抗体-尿激酶杂合基因的构建及其在中国仓鼠卵巢细胞中的表达

采用 DNA重组技术构建了表达鼠抗人纤维蛋白单链抗体与低分子量尿激酶融合基因的真核表达载体。通过磷酸钙共沉淀法 ,将该表达载体转染到中国仓鼠卵巢细胞二氢叶酸还原酶基因缺陷株 ( CHO- dhfr-)中 ,利用选择培养基筛选出稳定表达的细胞株 ,溶解圈法测定融合蛋白的表达水平为每 1 0 6细胞每天 5 8IU。该融合蛋白保留了与纤维蛋白的结合活性和溶解纤维蛋白的溶纤活性。SDS- PAGE,Western印迹法分析证明融合蛋白的相对分子质量约为 70× 1 0 3     

汉滩病毒核蛋白的分段表达及抗原表位分析

在大肠杆菌中对汉滩病毒Ｓ基因４种不同长度片段的重组表达质粒进行诱导表达。结果表明表达的４种ＧＳＴ－ＮＰ融合蛋白均以不溶性包含体形式存在于茵体细胞内,表达量分别占菌体蛋白总量的２９－３６％,分子量分别约为７２ｋＤ、６６ｋＤ、５４ｋＤ和４４ｋＤＤ。Ｗｅｓｔｅｒｎ ｂｌｏｔ显示５４ｋＤ和７２ｋＤ融合蛋白用酶标记汉滩病毒ＮＰＭｃＡｂｌＡ８和抗ＧＳＴ ＭｃＡｂ ３Ｃ１１染色呈阳反应。６６ｋＤ和４４ｋＤ融合蛋     

表达人乳头瘤病毒16型E6/E7融合蛋白的非复制型重组痘苗病毒的构建及免疫效果观察

采用基因工程方法将HPV16E6、E7基因融合后插入痘苗病毒载体,通过同源重组构建表达人乳头瘤病毒16型E6/E7融合蛋白的非复制型重组痘苗病毒疫苗,用C57BL/6小鼠观察其免疫原性和抗肿瘤移植情况。测序结果表明融合的HPV16E6、E7基因序列与设计相符;构建的非复制型重组痘苗病毒经Dot blot鉴定,显示有E6、E7融合基因的插入;Western blot检测表明该重组病毒在鸡胚成纤维细胞中能表达HPV16型E6/E7融合蛋白。动物免疫试验表明,该重组病毒在小鼠体内可诱发E6、E7特异性抗体;被免疫小鼠能抵抗TC-1肿瘤细胞的攻击。此结果为将来进一步研制HPV16、18型联合疫苗打下了基础。